Cargando…

Duchenne muscular dystrophy: Advances in molecular appraoch

Detalles Bibliográficos
Autores principales:	Benitto, Afaf, Hamzi, Khalil, Itri, Mohammed, Slassi, Ilham, Nadifi, Sellama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722623/ https://www.ncbi.nlm.nih.gov/pubmed/23901208 http://dx.doi.org/10.4103/0971-6866.112931

Ejemplares similares

Duchenne and Becker Muscular Dystrophy: Contribution of a Molecular and Immunohistochemical Analysis in Diagnosis in Morocco
por: Bellayou, Hanane, et al.
Publicado: (2009)

Large scale meta-analysis of genetic studies in ischemic stroke: Five genes involving 152,297 individuals
por: Hamzi, Khalil, et al.
Publicado: (2013)

Effect of the novel Moroccan BRCA1 and BRCA2 frameshift mutations
por: Tazzite, Amal, et al.
Publicado: (2013)

G894T endothelial nitric oxide synthase polymorphism and ischemic stroke in Morocco
por: Diakite, Brehima, et al.
Publicado: (2014)

Effect of Yoga and Ayurveda on Duchenne Muscular Dystrophy
por: Telles, Shirley, et al.
Publicado: (2011)

Prader-Willi syndrome: Methylation study or fluorescence in situ hybridization first?
por: Hamzi, Khalil, et al.
Publicado: (2010)

Large-scale meta-analysis of genetic studies in ischemic stroke: Five genes involving 152,797 individuals
por: Hamzi, Khalil, et al.
Publicado: (2011)

Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2019)

Celiac Disease in a Boy with Duchenne Muscular Dystrophy: A Double Jeopardy!
por: Sharawat, Indar K., et al.
Publicado: (2020)

A classical phenotype of Duchenne muscular dystrophy in a girl with X; autosome translocation
por: Uzunhan, Tuğce Aksu, et al.
Publicado: (2014)

Combination of regional anaesthetic techniques in a Duchenne Muscular Dystrophy carrier undergoing mastectomy
por: Rathi, Raksha, et al.
Publicado: (2021)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Spontaneous Coronary Artery Dissection in the Setting of Duchenne Muscular Dystrophy: More Questions Than Answers
por: Yalta, Kenan, et al.
Publicado: (2023)

Molecular Analysis and Diagnosis of Duchenne Muscular Dystrophy
por: Forrest, S. M., et al.
Publicado: (1988)

Cardiomyopathy in Duchenne Muscular Dystrophy: A Single-Center Experience
por: Kummitha, Karthikeyan, et al.
Publicado: (2022)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2015)

Association of Autism Spectrum Disorder with Pre-symptomatic Duchenne Muscular Dystrophy: Isolated Elevation of Transaminases as a Diagnostic Clue
por: Panda, Prateek K., et al.
Publicado: (2021)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
por: Finsterer, Josef, et al.
Publicado: (2016)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Family reflections: Duchenne Muscular Dystrophy
por: Gill, Omaira
Publicado: (2022)

Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023)

Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review)
por: Zhang, Tianyuan, et al.
Publicado: (2021)

COVID-19 in advanced Duchenne/Becker muscular dystrophy patients
por: Levine, Hagit, et al.
Publicado: (2021)

Letter to the Editor: In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
por: Muntoni, Francesco, et al.
Publicado: (2023)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Comment on: “Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients” by Etienne et al.
por: Campos, Juliane C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k3g1ucs52aqle8932th8fioh5m